Afya Limited (AFYA) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Cotizando a $13.76, Afya Limited (AFYA) es una empresa del sector Consumer Defensive valorada en 2B. La acción obtiene una puntuación de 56/100, una calificación moderada basada en 9 KPI cuantitativos.
Ultimo analisis: 7 feb 2026Afya Limited (AFYA) Descripción General del Negocio al Consumidor
Afya Limited (AFYA) is revolutionizing medical education in Brazil, boasting a robust network of campuses and cutting-edge digital health solutions, positioning it as a leader in lifelong learning for healthcare professionals with a compelling 20.1% profit margin and a 1.50% dividend yield.
Tesis de Inversión
Afya Limited presents a notable research candidate due to its dominant position in the rapidly growing Brazilian medical education market. With a P/E ratio of 10.02 and a healthy profit margin of 20.1%, Afya demonstrates strong financial performance. The company's expansion into digital health services further enhances its growth potential by providing recurring revenue streams and increasing customer engagement. A key value driver is the increasing demand for medical professionals in Brazil, coupled with Afya's ability to secure and operate a significant number of medical school seats. The company's beta of 0.51 suggests lower volatility compared to the broader market, making it a noteworthy option for risk-averse investors. Upcoming catalysts include the potential for further acquisitions of medical schools and the continued expansion of its digital health platform, driving long-term value creation.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Market capitalization of $1.40 billion, reflecting Afya's significant presence in the Brazilian medical education market.
- P/E ratio of 10.02, indicating a potentially undervalued stock compared to its earnings.
- Profit margin of 20.1%, showcasing strong profitability and efficient operations.
- Gross margin of 65.0%, demonstrating the high value of Afya's educational products and services.
- Dividend yield of 1.50%, providing investors with a steady income stream.
Competidores y Pares
Fortalezas
- Leading medical education group in Brazil.
- Comprehensive suite of educational products and services.
- Strong brand reputation and extensive network of campuses.
- Growing digital health services platform.
Debilidades
- Reliance on the Brazilian economy and regulatory environment.
- Potential for increased competition in the medical education market.
- Exposure to currency fluctuations.
- Dependence on government accreditation for medical programs.
Catalizadores
- Upcoming: Potential acquisitions of smaller medical schools to expand market share.
- Ongoing: Continued growth in digital health services subscriptions.
- Ongoing: Increasing demand for medical professionals in Brazil.
- Upcoming: Launch of new specialized educational programs.
- Ongoing: Strategic partnerships with healthcare institutions.
Riesgos
- Potential: Changes in government regulations affecting medical education accreditation.
- Potential: Economic downturn in Brazil impacting student enrollment and tuition payments.
- Ongoing: Increased competition from other educational institutions offering similar programs.
- Potential: Currency fluctuations affecting financial performance.
- Ongoing: Dependence on maintaining high-quality educational standards and student outcomes.
Oportunidades de crecimiento
- Expansion of Digital Health Services: Afya has a significant opportunity to expand its digital health services platform. The market for digital health solutions is rapidly growing, driven by the increasing adoption of technology in healthcare. By offering a comprehensive suite of digital tools and resources, Afya can attract a larger user base and generate recurring subscription revenue. This expansion can be achieved through strategic partnerships, new product development, and targeted marketing campaigns. The timeline for significant growth in this area is within the next 2-3 years.
- Acquisition of New Medical Schools: Afya can continue to grow by acquiring additional medical schools in Brazil. The Brazilian medical education market is fragmented, presenting opportunities for consolidation. By acquiring smaller institutions, Afya can expand its geographic reach, increase its student enrollment, and leverage its existing infrastructure and expertise. This strategy can be executed over the next 3-5 years, driving long-term growth and market share gains.
- Increased Enrollment in Existing Programs: Afya can focus on increasing enrollment in its existing medical education programs. With a network of 46 campuses and a strong reputation for quality education, Afya is well-positioned to attract more students. This can be achieved through targeted marketing, scholarships, and partnerships with healthcare institutions. Increased enrollment will directly translate into higher revenue and profitability. This is an ongoing opportunity with continuous improvement efforts.
- Development of New Educational Programs: Afya can develop new educational programs to meet the evolving needs of the healthcare industry. This includes offering specialized courses in areas such as telemedicine, data analytics, and artificial intelligence in healthcare. By expanding its program offerings, Afya can attract a wider range of students and generate new revenue streams. The timeline for developing and launching new programs is within the next 1-2 years.
- Strategic Partnerships with Healthcare Providers: Afya can form strategic partnerships with healthcare providers to offer practical training opportunities for its students. These partnerships can provide students with valuable hands-on experience and improve their job prospects after graduation. Additionally, partnerships can lead to research collaborations and the development of innovative healthcare solutions. These partnerships can be developed and expanded on an ongoing basis.
Oportunidades
- Expansion into new geographic markets within Brazil.
- Development of new educational programs and services.
- Strategic partnerships with healthcare providers.
- Acquisition of additional medical schools.
Amenazas
- Changes in government regulations affecting medical education.
- Economic downturn in Brazil impacting student enrollment.
- Increased competition from other educational institutions.
- Technological disruptions in the education sector.
Ventajas competitivas
- Strong brand reputation in the Brazilian medical education market.
- Extensive network of medical school campuses across Brazil.
- Comprehensive suite of educational products and services.
- Proprietary digital health platform with a large user base.
- High barriers to entry in the medical education market due to regulatory requirements.
Acerca de AFYA
Founded in 1999, Afya Limited has evolved into Brazil's premier medical education group. The company's core mission is to empower medical professionals throughout their careers by providing high-quality educational products and services. Starting with a vision to transform medical education, Afya has strategically expanded its offerings to include undergraduate medical schools, medical residency preparatory courses, graduate programs, and continuous education resources. Afya operates a network of 46 undergraduate and graduate medical school campuses, consisting of 30 operating units and five approved units as of December 31, 2021. These campuses house 2,731 medical school seats, including 2,481 operating seats and 278 approved seats, demonstrating Afya's significant capacity to educate future medical professionals. Beyond traditional education, Afya has embraced digital innovation through its digital health services, offering a subscription-based mobile app and website portal. This platform assists health professionals and students with clinical decision-making by providing tools such as medical calculators, charts, updated content, prescriptions, clinical scores, medical procedures, and laboratory exams. Afya's comprehensive approach, combining physical campuses with digital solutions, solidifies its position as a leader in the Brazilian medical education market.
Qué hacen
- Operate medical schools across Brazil.
- Provide medical residency preparatory courses.
- Offer graduate courses in healthcare-related fields.
- Provide digital health services through a subscription-based platform.
- Offer health sciences courses including medicine, dentistry, and nursing.
- Provide medical postgraduate specialization programs.
- Offer printed and digital content for medical education.
- Operate an online medical education platform.
Modelo de Negocio
- Tuition fees from undergraduate and graduate medical programs.
- Subscription revenue from digital health services platform.
- Revenue from medical residency preparatory courses.
- Sales of printed and digital educational content.
Contexto de la Industria
Afya Limited operates within the growing education and training services industry in Brazil, specifically focusing on medical education. The demand for qualified medical professionals in Brazil is increasing, driving growth in the medical education sector. The industry is characterized by a mix of public and private institutions, with Afya being one of the leading private players. Competition includes other educational groups and universities, but Afya differentiates itself through its comprehensive offerings, including digital health services and a large network of campuses. The Brazilian education market is expected to continue growing, driven by demographic trends and government initiatives to improve healthcare access.
Clientes Clave
- Undergraduate medical students.
- Medical residents preparing for specialization.
- Practicing healthcare professionals seeking continuing education.
- Hospitals and healthcare institutions using digital health services.
- Third-party medical schools utilizing Afya's resources.
Finanzas
Gráfico e información
Precio de la acción de Afya Limited (AFYA): $13.76 (+0.26, +1.93%)
Últimas noticias
-
A Look At Afya (NasdaqGS:AFYA) Valuation After Recent Mixed Share Price Performance
Yahoo! Finance: AFYA News · 14 mar 2026
-
Afya Ltd (AFYA) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Investments
Yahoo! Finance: AFYA News · 14 mar 2026
-
Reported earlier, Afya Sees FY2026 Sales $731.710M-$759.496M vs $763.950M Est
benzinga · 13 mar 2026
-
Afya's Q4 Adjusted Earnings, Revenue Increase; 2026 Revenue Guidance Issued
MT Newswires · 13 mar 2026
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para AFYA.
Objetivos de Precios
Objetivo de consenso: $16.75
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de AFYA en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Clasificación
Industria Education & Training ServicesCompetidores y Pares
Últimas Noticias
A Look At Afya (NasdaqGS:AFYA) Valuation After Recent Mixed Share Price Performance
Afya Ltd (AFYA) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Investments
Reported earlier, Afya Sees FY2026 Sales $731.710M-$759.496M vs $763.950M Est
Afya's Q4 Adjusted Earnings, Revenue Increase; 2026 Revenue Guidance Issued
Acciones de Afya Limited: Preguntas Clave Respondidas
¿Cuáles son los factores clave para evaluar AFYA?
Afya Limited (AFYA) actualmente tiene una puntuación IA de 56/100, indicando puntuación moderada. La acción cotiza a un P/E de 8.7x, por debajo del promedio del S&P 500 (~20-25x), potencialmente señalando valor. Los analistas apuntan a $16.75 (+22% desde $13.76). Fortaleza clave: Leading medical education group in Brazil.. Riesgo principal a monitorear: Potential: Changes in government regulations affecting medical education accreditation.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de AFYA?
AFYA actualmente puntúa 56/100 (Grado C) en el MoonshotScore, lo que sugiere calificación moderada. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de AFYA?
Los precios de AFYA se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre AFYA?
Los analistas han establecido un precio objetivo de consenso de $16.75 para AFYA, representando un potencial alcista del 22% desde el precio actual de $13.76. La cobertura incluye calificaciones de compra, mantener y venta, estimaciones de ganancias y recientes mejoras o rebajas. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en AFYA?
Las categorías de riesgo para AFYA incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Changes in government regulations affecting medical education accreditation.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de AFYA?
Afya Limited (AFYA) tiene una relación P/E de 8.7, que está por debajo del promedio del mercado, lo que puede sugerir valor relativo. La relación P/E compara el precio de la acción con sus ganancias por acción. Compare con el promedio del S&P 500 (~20-25x) para contexto. Esto no es asesoramiento financiero.
¿Está AFYA sobrevalorada o infravalorada?
Determinar si Afya Limited (AFYA) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Su relación P/E es 8.7. Objetivo de analistas $16.75 (+22% desde el precio actual). Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de AFYA?
Afya Limited (AFYA) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Information is based on data available as of 2026-02-07. Future performance is subject to market conditions and company-specific factors.